Search Results - Lars Wallentin

Refine Results
  1. 1

    Uppsala Clinical Research Center—development of a platform to promote national and international clinical science by Lars Wallentin, Bertil Lindahl

    Published in Upsala Journal of Medical Sciences (2019-01-01)
    Get full text
    Article


  2. 2

    Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic events by Sofia Attelind, Pär Hallberg, Mia Wadelius, Anna-Karin Hamberg, Agneta Siegbahn, Agneta Siegbahn, Christopher B. Granger, Renato D. Lopes, John H. Alexander, Lars Wallentin, Lars Wallentin, Niclas Eriksson

    Published in Frontiers in Genetics (2022-09-01)
    Get full text
    Article


  3. 3

    Serum Neurofilament Light Chain in Patients With Atrial Fibrillation by Karl Sjölin, Julia Aulin, Lars Wallentin, Niclas Eriksson, Claes Held, Kim Kultima, Jonas Oldgren, Joachim Burman

    Get full text
    Article


  4. 4

    Antibodies against MYC-Associated Zinc Finger Protein: An Independent Marker in Acute Coronary Syndrome? by Diana Ernst, Christian Widera, Niklas T. Baerlecken, Wolfgang Schlumberger, Cornelia Daehnrich, Reinhold E. Schmidt, Katja Gabrysch, Lars Wallentin, Torsten Witte

    Published in Frontiers in Immunology (2017-11-01)
    Get full text
    Article


  5. 5

    Body Mass Index and Association With Cardiovascular Outcomes in Patients With Stable Coronary Heart Disease – A STABILITY Substudy by Claes Held, Nermin Hadziosmanovic, Philip E. Aylward, Emil Hagström, Judith S. Hochman, Ralph A. H. Stewart, Harvey D. White, Lars Wallentin

    Get full text
    Article


  6. 6

    Neuroglial Biomarkers for Risk Assessment of Ischemic Stroke and Other Cardiovascular Events in Patients With Atrial Fibrillation Not Receiving Oral Anticoagulation by Julia Aulin, Karl Sjölin, Johan Lindbäck, Alexander P. Benz, John W. Eikelboom, Kim Kultima, Jonas Oldgren, Lars Wallentin, Joachim Burman

    Get full text
    Article


  7. 7

    Factor V Leiden Does Not Modify the Phenotype of Acute Coronary Syndrome or the Extent of Myocardial Necrosis by Bakhtawar K. Mahmoodi, Niclas Eriksson, Gerrit J. A. Vos, Karina Meijer, Agneta Siegbahn, Stefan James, Lars Wallentin, Jurriën M. ten Berg

    Get full text
    Article


  8. 8

    Development and validation of a quantitative Proximity Extension Assay instrument with 21 proteins associated with cardiovascular risk (CVD-21). by Agneta Siegbahn, Niclas Eriksson, Erika Assarsson, Martin Lundberg, Andrea Ballagi, Claes Held, Ralph A H Stewart, Harvey D White, Mikael Åberg, Lars Wallentin

    Published in PLoS ONE (2023-01-01)
    Get full text
    Article


  9. 9

    Development and validation of a quantitative Proximity Extension Assay instrument with 21 proteins associated with cardiovascular risk (CVD-21) by Agneta Siegbahn, Niclas Eriksson, Erika Assarsson, Martin Lundberg, Andrea Ballagi, Claes Held, Ralph A. H. Stewart, Harvey D. White, Mikael Åberg, Lars Wallentin

    Published in PLoS ONE (2023-01-01)
    Get full text
    Article


  10. 10

    Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights F... by Konstantinos I. Gkarmiris, Johan Lindbäck, John H. Alexander, Christopher B. Granger, Peter Kastner, Renato D. Lopes, André Ziegler, Jonas Oldgren, Agneta Siegbahn, Lars Wallentin, Ziad Hijazi

    Get full text
    Article


  11. 11

    Differential effect of clopidogrel and ticagrelor on leukocyte count in relation to patient characteristics, biomarkers and genotype: a PLATO substudy by Thomas A. Nelson, William A.E. Parker, Tatevik Ghukasyan Lakic, Johan Westerbergh, Stefan K. James, Agneta Siegbahn, Richard C. Becker, Anders Himmelmann, Lars Wallentin, Robert F. Storey

    Published in Platelets (2022-04-01)
    Get full text
    Article


  12. 12

    Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and P... by Thor Ueland, Axel Åkerblom, Tatevik Ghukasyan, Annika E. Michelsen, Pål Aukrust, Richard C. Becker, Maria Bertilsson, Anders Himmelmann, Stefan K. James, Agneta Siegbahn, Robert F. Storey, Frederic Kontny, Lars Wallentin

    Get full text
    Article


  13. 13

    Association of Different Estimates of Renal Function With Cardiovascular Mortality and Bleeding in Atrial Fibrillation by Ziad Hijazi, Christopher B. Granger, Stefan H. Hohnloser, Johan Westerbergh, Johan Lindbäck, John H. Alexander, Matyas Keltai, Alexander Parkhomenko, José L. López-Sendón, Renato D. Lopes, Agneta Siegbahn, Lars Wallentin

    Get full text
    Article


  14. 14

    Optimizing warfarin dosing for patients with atrial fibrillation using machine learning by Jeremy Petch, Walter Nelson, Mary Wu, Marzyeh Ghassemi, Alexander Benz, Mehdi Fatemi, Shuang Di, Anthony Carnicelli, Christopher Granger, Robert Giugliano, Hwanhee Hong, Manesh Patel, Lars Wallentin, John Eikelboom, Stuart J. Connolly

    Published in Scientific Reports (2024-02-01)
    Get full text
    Article


  15. 15

    Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study. by Lars Wallentin, Niclas Eriksson, Maciej Olszowka, Tanja B Grammer, Emil Hagström, Claes Held, Marcus E Kleber, Wolfgang Koenig, Winfried März, Ralph A H Stewart, Harvey D White, Mikael Åberg, Agneta Siegbahn

    Published in PLoS Medicine (2021-01-01)
    Get full text
    Article


  16. 16

    ProteinSeq: high-performance proteomic analyses by proximity ligation and next generation sequencing. by Spyros Darmanis, Rachel Yuan Nong, Johan Vänelid, Agneta Siegbahn, Olle Ericsson, Simon Fredriksson, Christofer Bäcklin, Marta Gut, Simon Heath, Ivo Glynne Gut, Lars Wallentin, Mats G Gustafsson, Masood Kamali-Moghaddam, Ulf Landegren

    Published in PLoS ONE (2011-01-01)
    Get full text
    Article


  17. 17

    Biomarker Concentrations and Their Temporal Changes in Patients With Myocardial Infarction and Nonobstructive Compared With Obstructive Coronary Arteries: Results From the PLATO Tr... by Marcus Hjort, Kai M. Eggers, Tatevik Ghukasyan Lakic, Johan Lindbäck, Andrzej Budaj, Jan H. Cornel, Evangelos Giannitsis, Hugo A. Katus, Agneta Siegbahn, Robert F. Storey, Richard C. Becker, Lars Wallentin, Bertil Lindahl

    Get full text
    Article


  18. 18

    Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient‐Level Meta‐Analysis From COMBINE AF by Linda S. Johnson, Alexander P. Benz, Ashkan Shoamanesh, John W. Eikelboom, Michael Ezekowitz, Robert P. Giugliano, Lars Wallentin, Christian T. Ruff, Renato D. Lopes, Sanjit Jolly, Richard Whitlock, Christopher B. Granger, Stuart Connolly, Jeffrey S. Healey

    Get full text
    Article


  19. 19

    Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time by Ziad Hijazi, Bertil Lindahl, Jonas Oldgren, Ulrika Andersson, Johan Lindbäck, Christopher B. Granger, John H. Alexander, Bernard J. Gersh, Michael Hanna, Veli‐Pekka Harjola, Elaine M. Hylek, Renato D. Lopes, Agneta Siegbahn, Lars Wallentin

    Get full text
    Article


  20. 20

    Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas by Ziad Hijazi, John H Alexander, Christopher B Granger, Agneta Siegbahn, Lars Wallentin, Raffaele De Caterina, Bernard J Gersh, Elaine M Hylek, Michael D Ezekowitz, Tymon Pol, Johan Lindbäck, M Cecilia Bahit, JW Eikelboom, Renato Lopes

    Published in Open Heart (2021-02-01)
    Get full text
    Article


Search Tools: